WallStSmart

Covista Inc. (CVSA)vsJIADE LIMITED Common stock (JDZG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Covista Inc. generates 7331% more annual revenue ($1.91B vs $25.70M). CVSA leads profitability with a 12.3% profit margin vs -41.2%. CVSA earns a higher WallStSmart Score of 59/100 (C).

CVSA

Buy

59

out of 100

Grade: C

Growth: 4.0Profit: 7.5Value: 7.0Quality: 6.5
Piotroski: 6/9Altman Z: 3.09

JDZG

Avoid

19

out of 100

Grade: F

Growth: 7.3Profit: 2.5Value: 5.0Quality: 8.5
Piotroski: 3/9Altman Z: 3.69

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CVSA3 strengths · Avg: 8.7/10
Altman Z-ScoreHealth
3.0910/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.888/10

Growing faster than its price suggests

P/E RatioValuation
17.5x8/10

Attractively priced relative to earnings

JDZG4 strengths · Avg: 9.8/10
Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
66.2%10/10

Revenue surging 66.2% year-over-year

Altman Z-ScoreHealth
3.6910/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.149/10

Conservative balance sheet, low leverage

Areas to Watch

CVSA2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
4.5%4/10

4.5% revenue growth

EPS GrowthGrowth
-24.6%2/10

Earnings declined 24.6%

JDZG4 concerns · Avg: 2.8/10
Market CapQuality
$274.00M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
2.3%3/10

ROE of 2.3% — below average capital efficiency

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

EPS GrowthGrowth
-91.4%2/10

Earnings declined 91.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : CVSA

The strongest argument for CVSA centers on Altman Z-Score, PEG Ratio, P/E Ratio. PEG of 0.88 suggests the stock is reasonably priced for its growth.

Bull Case : JDZG

The strongest argument for JDZG centers on Price/Book, Revenue Growth, Altman Z-Score. Revenue growth of 66.2% demonstrates continued momentum.

Bear Case : CVSA

The primary concerns for CVSA are Revenue Growth, EPS Growth.

Bear Case : JDZG

The primary concerns for JDZG are Market Cap, Return on Equity, Piotroski F-Score.

Key Dynamics to Monitor

CVSA profiles as a value stock while JDZG is a hypergrowth play — different risk/reward profiles.

JDZG carries more volatility with a beta of 2.02 — expect wider price swings.

JDZG is growing revenue faster at 66.2% — sustainability is the question.

CVSA generates stronger free cash flow (166M), providing more financial flexibility.

Bottom Line

CVSA scores higher overall (59/100 vs 19/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

JIADE LIMITED Common stock

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · China

JIADE LIMITED (Ticker: JDZG) is a forward-thinking entity in the e-commerce and technology sectors, committed to driving consumer engagement with innovative solutions. The company prioritizes sustainable growth through substantial investments in research and development, enabling it to stay ahead of market trends and technological advancements. Supported by a strong network of strategic partnerships and a focus on outstanding customer satisfaction, JIADE LIMITED positions itself as a viable investment opportunity that promises both growth potential and stability, appealing to institutional investors seeking long-term value.

Visit Website →

Want to dig deeper into these stocks?